Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 07:33:39 +0200Thu, 27 Jun 2024 14:23:00 +0200Human medicines European public assessment report (EPAR): Inhixa, enoxaparin sodium, Date of authorisation: 15/09/2016, Revision: 27, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/inhixaHuman medicines European public assessment report (EPAR): Inhixa, enoxaparin sodium, Date of authorisation: 15/09/2016, Revision: 27, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/inhixaThu, 27 Jun 2024 14:23:00 +0200Human medicineInhixa : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-4264_en_2.pdfInhixa : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-4264_en_2.pdfThu, 27 Jun 2024 13:10:00 +0200Human medicine